ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 80 filers reported holding ADURO BIOTECH INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $89,000 | -44.0% | 36,672 | -36.9% | 0.00% | – |
| Q1 2020 | $159,000 | +137.3% | 58,155 | +3.0% | 0.00% | – |
| Q4 2019 | $67,000 | -29.5% | 56,442 | -8.6% | 0.00% | – |
| Q2 2019 | $95,000 | -97.0% | 61,745 | -92.3% | 0.00% | -100.0% |
| Q1 2019 | $3,180,000 | -51.4% | 798,960 | -67.8% | 0.00% | -50.0% |
| Q4 2018 | $6,549,000 | -50.1% | 2,480,725 | +39.1% | 0.00% | -33.3% |
| Q3 2018 | $13,112,000 | +17.7% | 1,783,979 | +12.1% | 0.01% | +20.0% |
| Q2 2018 | $11,136,000 | +595.1% | 1,590,832 | +823.4% | 0.01% | +400.0% |
| Q1 2018 | $1,602,000 | +22.4% | 172,286 | -1.3% | 0.00% | 0.0% |
| Q4 2017 | $1,309,000 | +71.3% | 174,564 | +145.4% | 0.00% | 0.0% |
| Q1 2017 | $764,000 | -5.7% | 71,120 | +12.4% | 0.00% | 0.0% |
| Q1 2016 | $810,000 | -18.3% | 63,260 | +93.4% | 0.00% | 0.0% |
| Q2 2015 | $992,000 | – | 32,704 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 5,118,560 | $12,438,000 | 0.72% |
| Rubric Capital Management LP | 1,629,321 | $3,959,000 | 0.37% |
| Burrage Capital Management LLC | 135,898 | $330,000 | 0.26% |
| Artal Group S.A. | 902,500 | $2,193,000 | 0.05% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,141,278 | $2,773,000 | 0.05% |
| Point72 Asset Management, L.P. | 2,050,000 | $4,982,000 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 567,181 | $1,378,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 34,241 | $83,000 | 0.01% |
| Renaissance Technologies | 4,384,010 | $10,653,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 802,749 | $1,951,000 | 0.01% |